At the beginning of 2017, scientists from the Biotechnology Institute of the Czech Academy of Science made a breakthrough announcement in the BIOCEV Center. In cooperation with our company Smart Brain, they have developed MitoTam, a substance capable of eliminating tumor cells of one of the most aggressive forms of breast cancer.
effective in suppressing breast cancer
in the General University Hospital in Prague
Targeting mitochondria, MitoTam is highly effective in suppressing breast cancer as well as other malignant diseases. Following the successful completion of laboratory and preclinical testing, the State Institute for Drug Control approved clinical testing of the drug. The trials are currently under way in the General University Hospital in Prague.